BPT Crunch

Companies on the Cutting Edge of Healthcare Innovations

back to Marketplace

Immunai

Immunai logo

Founded
2019
Geography
United States of America based
Funding
$295 M

Immunai was founded in December 2018. We are a multidisciplinary team of immunologists, genomics technologists, computer scientists, engineers, mathematicians and operators singularly focused on solving an audacious challenge. Backed by some of the leading scientific minds in immunology, oncology, and single cell genomics, we are up for the challenge.


immunology single-cell biology high-dimensional statistics

Technologies

AI Companies (Drug Discovery)  


Posts Mentioning This Company

Biopharma Insights

R&D Platform

Immunai combines comprehensive, multi-omic single cell genomics with cutting edge machine learning algorithms to enable high resolution profiling of the immune system, at industrial scale, with rapid turnaround.


Immunai’s immune profiling platform

Read more

Pipelines

No pipelines published yet

Products

 

Services

No services posted yet